Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 25 clinical trials
Camrelizumab Combined With Radiotherapy and Chemotherapy for the Treatment of Recurrent or Metastatic Cervical Cancer

To evaluate the effectiveness and safety of camrelizumab combined with radiotherapy and chemotherapy for recurrent or metastatic cervical cancer

  • 0 views
  • 20 May, 2021
  • 1 location
A Study of SHR-1210± SHR-1020 Versus Chemotherapy in Patients With Recurrent or Metastatic Cervical Cancer

cervical cancer patients. All enrolled patients will be randomly divided into 3 groups and receive treatment until disease progression, intolerable toxicity,any criterion for stopping the study drug or SHR

  • 2 views
  • 22 Mar, 2022
  • 1 location
Tisotumab Vedotin vs Chemotherapy in Recurrent or Metastatic Cervical Cancer (innovaTV 301)

This trial is being done to find out whether tisotumab vedotin works better than chemotherapy to treat cervical cancer. People in this study have cervical cancer that has spread to other parts of the body (metastatic) or has come back after being treated (recurrent). Participants in this trial will be …

bevacizumab
pemetrexed
tisotumab vedotin
chemotherapy drugs
carboplatin
  • 3 views
  • 29 Jul, 2022
  • 88 locations
A Study of SHR-1701 Plus Platinum-containing Chemotherapy With or Without BP102 (Bevacizumab) as First-line Treatment in Cervical Cancer

, Recurrent, or Metastatic Cervical Cancer.

bevacizumab
carcinoma
squamous cell carcinoma
carboplatin
adenocarcinoma
  • 0 views
  • 24 Apr, 2022
  • 1 location
Ultrafractionated Radiation Therapy for Metastatic Cervical Cancer

To improve overall survival in patients with metastatic cervical cancer by loco-regional therapy with ultra-fractionated radiation therapy

metastasis
metastatic cervical cancer
cancer
measurable disease
hysterectomy
  • 0 views
  • 10 May, 2022
  • 1 location
A Clinical Study of PD-L1 Antibody ZKAB001(Drug Code) in Recurrent or Metastatic Cervical Cancer

targeting the Programmed Death - Ligand 1 (PD-L1) membrane receptor on T lymphocytes and other cells of the immune system) administered every 14 days in subjects with recurrent or metastatic cervical cancer

metastasis
adjuvant therapy
metastatic cervical cancer
immunomodulator
monoclonal antibodies
  • 30 views
  • 14 Feb, 2022
  • 1 location
Study of GLS-010 Injection in Patients With Recurrent or Metastatic Cervical Cancer (CC)

Patients with recurrent or metastatic cervical cancerand will be treated with GLS-010.

cancer
metastatic cervical cancer
aptt
  • 4 views
  • 09 Feb, 2022
Study of the SG001 Injection for Patients With Relapsed or Metastatic Uterine Cervical Cancer

This study is an open, single-arm, multicenter phase II study to investigate the efficacy and safety of SG001 for relapsed or metastatic uterine cervical cancer patients with PD-L1 positive

neutrophil count
carcinoma
squamous cell carcinoma
adenocarcinoma
anticoagulant
  • 0 views
  • 30 Nov, 2021
  • 1 location
SBRT and Atezolizumab in the Management of Recurrent, Persistent, or Metastatic Cervical Cancer

in patients with recurrent, persistent, or metastatic cervical cancer.

atezolizumab
squamous cell carcinoma
human papilloma virus vaccine
MRI
adenocarcinoma
  • 38 views
  • 07 Jul, 2022
  • 2 locations
Study of Niraparib With Radiotherapy for Treatment of Metastatic Invasive Carcinoma of the Cervix (NIVIX)

The most effective strategy for managing distantly metastatic invasive carcinomas of the cervix is not defined. Based on the success of niraparib in breast and ovarian cancer trials and the concern for toxicities and comorbidities limiting the compliance of concurrent cisplatin for cervical cancer, this study is a phase I/II …

  • 0 views
  • 10 May, 2022
  • 1 location